nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—ABCG2—Sulfasalazine—Crohn's disease	0.209	0.421	CbGbCtD
Buprenorphine—CYP3A5—Sulfasalazine—Crohn's disease	0.116	0.234	CbGbCtD
Buprenorphine—CYP2C19—Prednisone—Crohn's disease	0.0748	0.151	CbGbCtD
Buprenorphine—ABCB1—Prednisone—Crohn's disease	0.0604	0.121	CbGbCtD
Buprenorphine—CYP3A4—Prednisone—Crohn's disease	0.0362	0.0728	CbGbCtD
Buprenorphine—Naloxone—TLR4—Crohn's disease	0.0123	0.889	CrCbGaD
Buprenorphine—Upset stomach—Mesalazine—Crohn's disease	0.00429	0.0133	CcSEcCtD
Buprenorphine—Pharyngolaryngeal pain—Mesalazine—Crohn's disease	0.00416	0.0129	CcSEcCtD
Buprenorphine—Laryngeal pain—Mesalazine—Crohn's disease	0.00412	0.0128	CcSEcCtD
Buprenorphine—Rigors—Azathioprine—Crohn's disease	0.00378	0.0117	CcSEcCtD
Buprenorphine—Amblyopia—Mesalazine—Crohn's disease	0.00364	0.0113	CcSEcCtD
Buprenorphine—Feeling hot—Mesalazine—Crohn's disease	0.00358	0.0111	CcSEcCtD
Buprenorphine—Withdrawal syndrome—Prednisone—Crohn's disease	0.00356	0.0111	CcSEcCtD
Buprenorphine—Rash pustular—Mesalazine—Crohn's disease	0.00352	0.0109	CcSEcCtD
Buprenorphine—Breast disorder—Mercaptopurine—Crohn's disease	0.00339	0.0105	CcSEcCtD
Buprenorphine—Vasodilation—Mesalazine—Crohn's disease	0.0032	0.00993	CcSEcCtD
Buprenorphine—Vasodilation procedure—Mesalazine—Crohn's disease	0.0032	0.00993	CcSEcCtD
Buprenorphine—Dysmenorrhoea—Mesalazine—Crohn's disease	0.00309	0.0096	CcSEcCtD
Buprenorphine—Drug withdrawal syndrome—Prednisone—Crohn's disease	0.00303	0.00942	CcSEcCtD
Buprenorphine—Neck pain—Mesalazine—Crohn's disease	0.00284	0.00883	CcSEcCtD
Buprenorphine—Musculoskeletal pain—Mesalazine—Crohn's disease	0.00284	0.00883	CcSEcCtD
Buprenorphine—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.00274	0.00851	CcSEcCtD
Buprenorphine—Influenza like illness—Mesalazine—Crohn's disease	0.00273	0.00848	CcSEcCtD
Buprenorphine—Dry eye—Mesalazine—Crohn's disease	0.00259	0.00806	CcSEcCtD
Buprenorphine—Coma—Mesalazine—Crohn's disease	0.00257	0.00798	CcSEcCtD
Buprenorphine—Ear pain—Mesalazine—Crohn's disease	0.00239	0.00743	CcSEcCtD
Buprenorphine—Immune system disorder—Mercaptopurine—Crohn's disease	0.00235	0.00729	CcSEcCtD
Buprenorphine—Disorientation—Mesalazine—Crohn's disease	0.00228	0.00708	CcSEcCtD
Buprenorphine—Malnutrition—Mercaptopurine—Crohn's disease	0.00226	0.00703	CcSEcCtD
Buprenorphine—Libido decreased—Mesalazine—Crohn's disease	0.0022	0.00683	CcSEcCtD
Buprenorphine—Lethargy—Mesalazine—Crohn's disease	0.00208	0.00647	CcSEcCtD
Buprenorphine—Osteoarthritis—Mesalazine—Crohn's disease	0.00204	0.00634	CcSEcCtD
Buprenorphine—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.00202	0.00629	CcSEcCtD
Buprenorphine—Affect lability—Mesalazine—Crohn's disease	0.00201	0.00624	CcSEcCtD
Buprenorphine—Migraine—Mesalazine—Crohn's disease	0.00201	0.00624	CcSEcCtD
Buprenorphine—Face oedema—Mesalazine—Crohn's disease	0.00197	0.00612	CcSEcCtD
Buprenorphine—Mood swings—Mesalazine—Crohn's disease	0.00193	0.006	CcSEcCtD
Buprenorphine—Arthralgia—Mercaptopurine—Crohn's disease	0.00193	0.00599	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00191	0.00594	CcSEcCtD
Buprenorphine—Memory impairment—Prednisone—Crohn's disease	0.00189	0.00588	CcSEcCtD
Buprenorphine—Abscess—Prednisone—Crohn's disease	0.00188	0.00584	CcSEcCtD
Buprenorphine—Dry skin—Mesalazine—Crohn's disease	0.00187	0.00581	CcSEcCtD
Buprenorphine—Abdominal pain upper—Mesalazine—Crohn's disease	0.00186	0.00579	CcSEcCtD
Buprenorphine—Orthostatic hypotension—Mesalazine—Crohn's disease	0.00186	0.00579	CcSEcCtD
Buprenorphine—Abdominal discomfort—Azathioprine—Crohn's disease	0.00185	0.00576	CcSEcCtD
Buprenorphine—Oedema—Mercaptopurine—Crohn's disease	0.00185	0.00574	CcSEcCtD
Buprenorphine—Breast disorder—Mesalazine—Crohn's disease	0.00184	0.00573	CcSEcCtD
Buprenorphine—Cramp muscle—Mesalazine—Crohn's disease	0.00184	0.00571	CcSEcCtD
Buprenorphine—Nasopharyngitis—Mesalazine—Crohn's disease	0.00182	0.00567	CcSEcCtD
Buprenorphine—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.0018	0.00559	CcSEcCtD
Buprenorphine—Skin disorder—Mercaptopurine—Crohn's disease	0.00179	0.00557	CcSEcCtD
Buprenorphine—Abdominal distension—Mesalazine—Crohn's disease	0.00177	0.00551	CcSEcCtD
Buprenorphine—Dysphagia—Mesalazine—Crohn's disease	0.00176	0.00548	CcSEcCtD
Buprenorphine—Asthma—Mesalazine—Crohn's disease	0.00176	0.00548	CcSEcCtD
Buprenorphine—Influenza—Mesalazine—Crohn's disease	0.00176	0.00548	CcSEcCtD
Buprenorphine—Anorexia—Mercaptopurine—Crohn's disease	0.00176	0.00547	CcSEcCtD
Buprenorphine—Bronchospasm—Mesalazine—Crohn's disease	0.00173	0.00539	CcSEcCtD
Buprenorphine—Infestation—Azathioprine—Crohn's disease	0.00172	0.00536	CcSEcCtD
Buprenorphine—Infestation NOS—Azathioprine—Crohn's disease	0.00172	0.00536	CcSEcCtD
Buprenorphine—Angina pectoris—Mesalazine—Crohn's disease	0.00172	0.00533	CcSEcCtD
Buprenorphine—Bronchitis—Mesalazine—Crohn's disease	0.00169	0.00527	CcSEcCtD
Buprenorphine—Abdominal discomfort—Mesalazine—Crohn's disease	0.00169	0.00525	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00168	0.00523	CcSEcCtD
Buprenorphine—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00164	0.00509	CcSEcCtD
Buprenorphine—Hepatobiliary disease—Azathioprine—Crohn's disease	0.00163	0.00507	CcSEcCtD
Buprenorphine—Decreased appetite—Mercaptopurine—Crohn's disease	0.0016	0.00499	CcSEcCtD
Buprenorphine—Weight decreased—Mesalazine—Crohn's disease	0.00159	0.00495	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00159	0.00495	CcSEcCtD
Buprenorphine—Infestation NOS—Mesalazine—Crohn's disease	0.00157	0.00488	CcSEcCtD
Buprenorphine—Infestation—Mesalazine—Crohn's disease	0.00157	0.00488	CcSEcCtD
Buprenorphine—Depression—Mesalazine—Crohn's disease	0.00157	0.00487	CcSEcCtD
Buprenorphine—Naloxone—ALB—Crohn's disease	0.00153	0.111	CrCbGaD
Buprenorphine—Urinary tract infection—Mesalazine—Crohn's disease	0.00153	0.00475	CcSEcCtD
Buprenorphine—Conjunctivitis—Mesalazine—Crohn's disease	0.00153	0.00475	CcSEcCtD
Buprenorphine—Sweating—Mesalazine—Crohn's disease	0.00151	0.00468	CcSEcCtD
Buprenorphine—Hiccups—Prednisone—Crohn's disease	0.00149	0.00462	CcSEcCtD
Buprenorphine—Hepatobiliary disease—Mesalazine—Crohn's disease	0.00149	0.00462	CcSEcCtD
Buprenorphine—Sinusitis—Mesalazine—Crohn's disease	0.00147	0.00458	CcSEcCtD
Buprenorphine—Body temperature increased—Mercaptopurine—Crohn's disease	0.00146	0.00454	CcSEcCtD
Buprenorphine—Rhinitis—Mesalazine—Crohn's disease	0.00141	0.00439	CcSEcCtD
Buprenorphine—Pharyngitis—Mesalazine—Crohn's disease	0.0014	0.00435	CcSEcCtD
Buprenorphine—Immune system disorder—Azathioprine—Crohn's disease	0.0014	0.00435	CcSEcCtD
Buprenorphine—Mediastinal disorder—Azathioprine—Crohn's disease	0.0014	0.00434	CcSEcCtD
Buprenorphine—Urinary tract disorder—Mesalazine—Crohn's disease	0.00139	0.00433	CcSEcCtD
Buprenorphine—Oedema peripheral—Mesalazine—Crohn's disease	0.00139	0.00432	CcSEcCtD
Buprenorphine—Chills—Azathioprine—Crohn's disease	0.00139	0.00432	CcSEcCtD
Buprenorphine—Connective tissue disorder—Mesalazine—Crohn's disease	0.00139	0.00431	CcSEcCtD
Buprenorphine—Urethral disorder—Mesalazine—Crohn's disease	0.00138	0.0043	CcSEcCtD
Buprenorphine—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00136	0.00423	CcSEcCtD
Buprenorphine—Eye disorder—Mesalazine—Crohn's disease	0.00132	0.0041	CcSEcCtD
Buprenorphine—Tinnitus—Mesalazine—Crohn's disease	0.00131	0.00409	CcSEcCtD
Buprenorphine—Cardiac disorder—Mesalazine—Crohn's disease	0.00131	0.00407	CcSEcCtD
Buprenorphine—Angiopathy—Mesalazine—Crohn's disease	0.00128	0.00398	CcSEcCtD
Buprenorphine—Euphoric mood—Prednisone—Crohn's disease	0.00128	0.00397	CcSEcCtD
Buprenorphine—Immune system disorder—Mesalazine—Crohn's disease	0.00127	0.00396	CcSEcCtD
Buprenorphine—Mediastinal disorder—Mesalazine—Crohn's disease	0.00127	0.00395	CcSEcCtD
Buprenorphine—Chills—Mesalazine—Crohn's disease	0.00127	0.00393	CcSEcCtD
Buprenorphine—Diarrhoea—Mercaptopurine—Crohn's disease	0.00126	0.00393	CcSEcCtD
Buprenorphine—Ill-defined disorder—Azathioprine—Crohn's disease	0.00125	0.00389	CcSEcCtD
Buprenorphine—Mental disorder—Mesalazine—Crohn's disease	0.00124	0.00384	CcSEcCtD
Buprenorphine—Erythema—Mesalazine—Crohn's disease	0.00123	0.00382	CcSEcCtD
Buprenorphine—Malaise—Azathioprine—Crohn's disease	0.00122	0.00378	CcSEcCtD
Buprenorphine—Flatulence—Mesalazine—Crohn's disease	0.00121	0.00376	CcSEcCtD
Buprenorphine—Tension—Mesalazine—Crohn's disease	0.0012	0.00374	CcSEcCtD
Buprenorphine—Dysgeusia—Mesalazine—Crohn's disease	0.0012	0.00374	CcSEcCtD
Buprenorphine—Nervousness—Mesalazine—Crohn's disease	0.00119	0.00371	CcSEcCtD
Buprenorphine—Back pain—Mesalazine—Crohn's disease	0.00119	0.00369	CcSEcCtD
Buprenorphine—Muscle spasms—Mesalazine—Crohn's disease	0.00118	0.00367	CcSEcCtD
Buprenorphine—Vomiting—Mercaptopurine—Crohn's disease	0.00117	0.00365	CcSEcCtD
Buprenorphine—Injury—Prednisone—Crohn's disease	0.00117	0.00365	CcSEcCtD
Buprenorphine—Rash—Mercaptopurine—Crohn's disease	0.00116	0.00362	CcSEcCtD
Buprenorphine—Dermatitis—Mercaptopurine—Crohn's disease	0.00116	0.00361	CcSEcCtD
Buprenorphine—Vision blurred—Mesalazine—Crohn's disease	0.00116	0.0036	CcSEcCtD
Buprenorphine—Tremor—Mesalazine—Crohn's disease	0.00115	0.00357	CcSEcCtD
Buprenorphine—Arthralgia—Azathioprine—Crohn's disease	0.00115	0.00357	CcSEcCtD
Buprenorphine—Myalgia—Azathioprine—Crohn's disease	0.00115	0.00357	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00114	0.00354	CcSEcCtD
Buprenorphine—Ill-defined disorder—Mesalazine—Crohn's disease	0.00114	0.00354	CcSEcCtD
Buprenorphine—Discomfort—Azathioprine—Crohn's disease	0.00113	0.00352	CcSEcCtD
Buprenorphine—Angioedema—Mesalazine—Crohn's disease	0.00112	0.00349	CcSEcCtD
Buprenorphine—Malaise—Mesalazine—Crohn's disease	0.00111	0.00344	CcSEcCtD
Buprenorphine—Vertigo—Mesalazine—Crohn's disease	0.0011	0.00343	CcSEcCtD
Buprenorphine—Syncope—Mesalazine—Crohn's disease	0.0011	0.00342	CcSEcCtD
Buprenorphine—Lethargy—Prednisone—Crohn's disease	0.0011	0.00342	CcSEcCtD
Buprenorphine—Nausea—Mercaptopurine—Crohn's disease	0.0011	0.00341	CcSEcCtD
Buprenorphine—Infection—Azathioprine—Crohn's disease	0.00109	0.0034	CcSEcCtD
Buprenorphine—Palpitations—Mesalazine—Crohn's disease	0.00108	0.00337	CcSEcCtD
Buprenorphine—Loss of consciousness—Mesalazine—Crohn's disease	0.00108	0.00335	CcSEcCtD
Buprenorphine—Osteoarthritis—Prednisone—Crohn's disease	0.00108	0.00335	CcSEcCtD
Buprenorphine—Cough—Mesalazine—Crohn's disease	0.00107	0.00333	CcSEcCtD
Buprenorphine—Skin disorder—Azathioprine—Crohn's disease	0.00107	0.00332	CcSEcCtD
Buprenorphine—Affect lability—Prednisone—Crohn's disease	0.00106	0.0033	CcSEcCtD
Buprenorphine—Hypertension—Mesalazine—Crohn's disease	0.00106	0.00329	CcSEcCtD
Buprenorphine—Psychotic disorder—Prednisone—Crohn's disease	0.00105	0.00327	CcSEcCtD
Buprenorphine—Arthralgia—Mesalazine—Crohn's disease	0.00105	0.00325	CcSEcCtD
Buprenorphine—Chest pain—Mesalazine—Crohn's disease	0.00105	0.00325	CcSEcCtD
Buprenorphine—Myalgia—Mesalazine—Crohn's disease	0.00105	0.00325	CcSEcCtD
Buprenorphine—Anxiety—Mesalazine—Crohn's disease	0.00104	0.00324	CcSEcCtD
Buprenorphine—Face oedema—Prednisone—Crohn's disease	0.00104	0.00324	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00104	0.00323	CcSEcCtD
Buprenorphine—Discomfort—Mesalazine—Crohn's disease	0.00103	0.00321	CcSEcCtD
Buprenorphine—Hypotension—Azathioprine—Crohn's disease	0.00103	0.00319	CcSEcCtD
Buprenorphine—Dry mouth—Mesalazine—Crohn's disease	0.00102	0.00318	CcSEcCtD
Buprenorphine—Mood swings—Prednisone—Crohn's disease	0.00102	0.00318	CcSEcCtD
Buprenorphine—Confusional state—Mesalazine—Crohn's disease	0.00101	0.00314	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.001	0.00311	CcSEcCtD
Buprenorphine—Anaphylactic shock—Mesalazine—Crohn's disease	0.001	0.00311	CcSEcCtD
Buprenorphine—Oedema—Mesalazine—Crohn's disease	0.001	0.00311	CcSEcCtD
Buprenorphine—Infection—Mesalazine—Crohn's disease	0.000995	0.00309	CcSEcCtD
Buprenorphine—Dry skin—Prednisone—Crohn's disease	0.000988	0.00307	CcSEcCtD
Buprenorphine—Shock—Mesalazine—Crohn's disease	0.000986	0.00306	CcSEcCtD
Buprenorphine—Nervous system disorder—Mesalazine—Crohn's disease	0.000982	0.00305	CcSEcCtD
Buprenorphine—Tachycardia—Mesalazine—Crohn's disease	0.000978	0.00304	CcSEcCtD
Buprenorphine—Skin disorder—Mesalazine—Crohn's disease	0.000973	0.00302	CcSEcCtD
Buprenorphine—Hyperhidrosis—Mesalazine—Crohn's disease	0.000968	0.00301	CcSEcCtD
Buprenorphine—Anorexia—Mesalazine—Crohn's disease	0.000955	0.00297	CcSEcCtD
Buprenorphine—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.000951	0.00296	CcSEcCtD
Buprenorphine—Muscular weakness—Prednisone—Crohn's disease	0.000951	0.00296	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000949	0.00295	CcSEcCtD
Buprenorphine—Abdominal distension—Prednisone—Crohn's disease	0.000938	0.00292	CcSEcCtD
Buprenorphine—Hypotension—Mesalazine—Crohn's disease	0.000936	0.00291	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000913	0.00284	CcSEcCtD
Buprenorphine—Feeling abnormal—Azathioprine—Crohn's disease	0.000906	0.00282	CcSEcCtD
Buprenorphine—Insomnia—Mesalazine—Crohn's disease	0.000906	0.00282	CcSEcCtD
Buprenorphine—Paraesthesia—Mesalazine—Crohn's disease	0.0009	0.0028	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000899	0.0028	CcSEcCtD
Buprenorphine—Dyspnoea—Mesalazine—Crohn's disease	0.000893	0.00278	CcSEcCtD
Buprenorphine—Somnolence—Mesalazine—Crohn's disease	0.000891	0.00277	CcSEcCtD
Buprenorphine—Dyspepsia—Mesalazine—Crohn's disease	0.000882	0.00274	CcSEcCtD
Buprenorphine—Decreased appetite—Mesalazine—Crohn's disease	0.000871	0.00271	CcSEcCtD
Buprenorphine—Body temperature increased—Azathioprine—Crohn's disease	0.000869	0.0027	CcSEcCtD
Buprenorphine—Abdominal pain—Azathioprine—Crohn's disease	0.000869	0.0027	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000865	0.00269	CcSEcCtD
Buprenorphine—Fatigue—Mesalazine—Crohn's disease	0.000864	0.00268	CcSEcCtD
Buprenorphine—Pain—Mesalazine—Crohn's disease	0.000857	0.00266	CcSEcCtD
Buprenorphine—Constipation—Mesalazine—Crohn's disease	0.000857	0.00266	CcSEcCtD
Buprenorphine—Weight decreased—Prednisone—Crohn's disease	0.000843	0.00262	CcSEcCtD
Buprenorphine—Depression—Prednisone—Crohn's disease	0.000829	0.00258	CcSEcCtD
Buprenorphine—Feeling abnormal—Mesalazine—Crohn's disease	0.000826	0.00257	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000819	0.00255	CcSEcCtD
Buprenorphine—Hypersensitivity—Azathioprine—Crohn's disease	0.00081	0.00252	CcSEcCtD
Buprenorphine—Urticaria—Mesalazine—Crohn's disease	0.000796	0.00247	CcSEcCtD
Buprenorphine—Abdominal pain—Mesalazine—Crohn's disease	0.000792	0.00246	CcSEcCtD
Buprenorphine—Body temperature increased—Mesalazine—Crohn's disease	0.000792	0.00246	CcSEcCtD
Buprenorphine—Bradycardia—Prednisone—Crohn's disease	0.000759	0.00236	CcSEcCtD
Buprenorphine—Diarrhoea—Azathioprine—Crohn's disease	0.000752	0.00234	CcSEcCtD
Buprenorphine—Hallucination—Prednisone—Crohn's disease	0.000742	0.00231	CcSEcCtD
Buprenorphine—Hypersensitivity—Mesalazine—Crohn's disease	0.000738	0.00229	CcSEcCtD
Buprenorphine—Connective tissue disorder—Prednisone—Crohn's disease	0.000733	0.00228	CcSEcCtD
Buprenorphine—Dizziness—Azathioprine—Crohn's disease	0.000727	0.00226	CcSEcCtD
Buprenorphine—Asthenia—Mesalazine—Crohn's disease	0.000719	0.00223	CcSEcCtD
Buprenorphine—Pruritus—Mesalazine—Crohn's disease	0.000709	0.0022	CcSEcCtD
Buprenorphine—Vomiting—Azathioprine—Crohn's disease	0.000699	0.00217	CcSEcCtD
Buprenorphine—Eye disorder—Prednisone—Crohn's disease	0.000697	0.00217	CcSEcCtD
Buprenorphine—Rash—Azathioprine—Crohn's disease	0.000693	0.00216	CcSEcCtD
Buprenorphine—Dermatitis—Azathioprine—Crohn's disease	0.000693	0.00215	CcSEcCtD
Buprenorphine—Flushing—Prednisone—Crohn's disease	0.000692	0.00215	CcSEcCtD
Buprenorphine—Headache—Azathioprine—Crohn's disease	0.000689	0.00214	CcSEcCtD
Buprenorphine—Diarrhoea—Mesalazine—Crohn's disease	0.000685	0.00213	CcSEcCtD
Buprenorphine—Angiopathy—Prednisone—Crohn's disease	0.000677	0.0021	CcSEcCtD
Buprenorphine—Immune system disorder—Prednisone—Crohn's disease	0.000674	0.00209	CcSEcCtD
Buprenorphine—Dizziness—Mesalazine—Crohn's disease	0.000662	0.00206	CcSEcCtD
Buprenorphine—Mental disorder—Prednisone—Crohn's disease	0.000654	0.00203	CcSEcCtD
Buprenorphine—Nausea—Azathioprine—Crohn's disease	0.000653	0.00203	CcSEcCtD
Buprenorphine—Erythema—Prednisone—Crohn's disease	0.000649	0.00202	CcSEcCtD
Buprenorphine—Malnutrition—Prednisone—Crohn's disease	0.000649	0.00202	CcSEcCtD
Buprenorphine—Vomiting—Mesalazine—Crohn's disease	0.000637	0.00198	CcSEcCtD
Buprenorphine—Rash—Mesalazine—Crohn's disease	0.000632	0.00196	CcSEcCtD
Buprenorphine—Dermatitis—Mesalazine—Crohn's disease	0.000631	0.00196	CcSEcCtD
Buprenorphine—Headache—Mesalazine—Crohn's disease	0.000628	0.00195	CcSEcCtD
Buprenorphine—Vision blurred—Prednisone—Crohn's disease	0.000612	0.0019	CcSEcCtD
Buprenorphine—Ill-defined disorder—Prednisone—Crohn's disease	0.000603	0.00187	CcSEcCtD
Buprenorphine—Agitation—Prednisone—Crohn's disease	0.000597	0.00186	CcSEcCtD
Buprenorphine—Nausea—Mesalazine—Crohn's disease	0.000595	0.00185	CcSEcCtD
Buprenorphine—Angioedema—Prednisone—Crohn's disease	0.000593	0.00184	CcSEcCtD
Buprenorphine—Malaise—Prednisone—Crohn's disease	0.000586	0.00182	CcSEcCtD
Buprenorphine—Vertigo—Prednisone—Crohn's disease	0.000583	0.00181	CcSEcCtD
Buprenorphine—Syncope—Prednisone—Crohn's disease	0.000582	0.00181	CcSEcCtD
Buprenorphine—Loss of consciousness—Prednisone—Crohn's disease	0.000571	0.00177	CcSEcCtD
Buprenorphine—Convulsion—Prednisone—Crohn's disease	0.000563	0.00175	CcSEcCtD
Buprenorphine—Hypertension—Prednisone—Crohn's disease	0.000561	0.00174	CcSEcCtD
Buprenorphine—Myalgia—Prednisone—Crohn's disease	0.000553	0.00172	CcSEcCtD
Buprenorphine—Arthralgia—Prednisone—Crohn's disease	0.000553	0.00172	CcSEcCtD
Buprenorphine—Anxiety—Prednisone—Crohn's disease	0.000551	0.00171	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000549	0.00171	CcSEcCtD
Buprenorphine—Discomfort—Prednisone—Crohn's disease	0.000546	0.0017	CcSEcCtD
Buprenorphine—Anaphylactic shock—Prednisone—Crohn's disease	0.00053	0.00165	CcSEcCtD
Buprenorphine—Oedema—Prednisone—Crohn's disease	0.00053	0.00165	CcSEcCtD
Buprenorphine—Infection—Prednisone—Crohn's disease	0.000527	0.00164	CcSEcCtD
Buprenorphine—Shock—Prednisone—Crohn's disease	0.000521	0.00162	CcSEcCtD
Buprenorphine—Nervous system disorder—Prednisone—Crohn's disease	0.00052	0.00162	CcSEcCtD
Buprenorphine—Tachycardia—Prednisone—Crohn's disease	0.000517	0.00161	CcSEcCtD
Buprenorphine—Skin disorder—Prednisone—Crohn's disease	0.000515	0.0016	CcSEcCtD
Buprenorphine—Hyperhidrosis—Prednisone—Crohn's disease	0.000512	0.00159	CcSEcCtD
Buprenorphine—Anorexia—Prednisone—Crohn's disease	0.000505	0.00157	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000483	0.0015	CcSEcCtD
Buprenorphine—Insomnia—Prednisone—Crohn's disease	0.000479	0.00149	CcSEcCtD
Buprenorphine—Paraesthesia—Prednisone—Crohn's disease	0.000476	0.00148	CcSEcCtD
Buprenorphine—Dyspepsia—Prednisone—Crohn's disease	0.000467	0.00145	CcSEcCtD
Buprenorphine—Decreased appetite—Prednisone—Crohn's disease	0.000461	0.00143	CcSEcCtD
Buprenorphine—Fatigue—Prednisone—Crohn's disease	0.000457	0.00142	CcSEcCtD
Buprenorphine—Constipation—Prednisone—Crohn's disease	0.000453	0.00141	CcSEcCtD
Buprenorphine—Feeling abnormal—Prednisone—Crohn's disease	0.000437	0.00136	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Prednisone—Crohn's disease	0.000433	0.00135	CcSEcCtD
Buprenorphine—Urticaria—Prednisone—Crohn's disease	0.000421	0.00131	CcSEcCtD
Buprenorphine—Abdominal pain—Prednisone—Crohn's disease	0.000419	0.0013	CcSEcCtD
Buprenorphine—Body temperature increased—Prednisone—Crohn's disease	0.000419	0.0013	CcSEcCtD
Buprenorphine—Hypersensitivity—Prednisone—Crohn's disease	0.000391	0.00121	CcSEcCtD
Buprenorphine—Asthenia—Prednisone—Crohn's disease	0.00038	0.00118	CcSEcCtD
Buprenorphine—Pruritus—Prednisone—Crohn's disease	0.000375	0.00117	CcSEcCtD
Buprenorphine—Diarrhoea—Prednisone—Crohn's disease	0.000363	0.00113	CcSEcCtD
Buprenorphine—Dizziness—Prednisone—Crohn's disease	0.00035	0.00109	CcSEcCtD
Buprenorphine—Vomiting—Prednisone—Crohn's disease	0.000337	0.00105	CcSEcCtD
Buprenorphine—Rash—Prednisone—Crohn's disease	0.000334	0.00104	CcSEcCtD
Buprenorphine—Dermatitis—Prednisone—Crohn's disease	0.000334	0.00104	CcSEcCtD
Buprenorphine—Headache—Prednisone—Crohn's disease	0.000332	0.00103	CcSEcCtD
Buprenorphine—Nausea—Prednisone—Crohn's disease	0.000315	0.000979	CcSEcCtD
Buprenorphine—OPRK1—GPCR downstream signaling—CCR6—Crohn's disease	0.000152	0.000905	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.00015	0.000897	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MLN—Crohn's disease	0.00015	0.000894	CbGpPWpGaD
Buprenorphine—OPRM1—TCR Signaling Pathway—IL6—Crohn's disease	0.000146	0.000872	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—IFNG—Crohn's disease	0.000146	0.000869	CbGpPWpGaD
Buprenorphine—OPRM1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.000143	0.000854	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR downstream signaling—JAK2—Crohn's disease	0.000143	0.000854	CbGpPWpGaD
Buprenorphine—OPRK1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000143	0.000852	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—SOCS1—Crohn's disease	0.000143	0.000852	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—MTMR3—Crohn's disease	0.000142	0.00085	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PLA2G4F—Crohn's disease	0.000142	0.000848	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—RSPO3—Crohn's disease	0.000142	0.000845	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PLA2G4F—Crohn's disease	0.000141	0.000841	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—FADS1—Crohn's disease	0.00014	0.000838	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CCR9—Crohn's disease	0.00014	0.000836	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000139	0.000832	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000139	0.000832	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—PTGER4—Crohn's disease	0.000138	0.000825	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000138	0.000822	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—CCR6—Crohn's disease	0.000138	0.000822	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000137	0.000818	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TAGAP—Crohn's disease	0.000137	0.000817	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—TYK2—Crohn's disease	0.000136	0.000813	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	0.000135	0.000808	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—SEL1L—Crohn's disease	0.000134	0.000801	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000133	0.000797	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—GPX4—Crohn's disease	0.000131	0.000784	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000131	0.000783	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000131	0.000779	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—GPR65—Crohn's disease	0.00013	0.000777	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—IL1B—Crohn's disease	0.00013	0.000775	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—JAK2—Crohn's disease	0.00013	0.000775	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—IL3—Crohn's disease	0.00013	0.000774	CbGpPWpGaD
Buprenorphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000129	0.000773	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PLA2G4F—Crohn's disease	0.000129	0.000771	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—CCR6—Crohn's disease	0.000128	0.000765	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—GCKR—Crohn's disease	0.000127	0.000758	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000125	0.000749	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—SMAD3—Crohn's disease	0.000123	0.000736	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000123	0.000733	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CCR9—Crohn's disease	0.000123	0.000733	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—PTGER4—Crohn's disease	0.000121	0.000724	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—MTMR3—Crohn's disease	0.000121	0.000721	CbGpPWpGaD
Buprenorphine—OPRM1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000121	0.00072	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—MTMR3—Crohn's disease	0.00012	0.000715	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—RSPO3—Crohn's disease	0.00012	0.000714	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—CXCL8—Crohn's disease	0.000119	0.000708	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—IL3—Crohn's disease	0.000118	0.000703	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000117	0.000699	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000117	0.000699	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CCR6—Crohn's disease	0.000116	0.000695	CbGpPWpGaD
Buprenorphine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	0.000116	0.000692	CbGpPWpGaD
Buprenorphine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	0.000116	0.000692	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—GPR65—Crohn's disease	0.000114	0.000681	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—IL2RA—Crohn's disease	0.000114	0.000681	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000114	0.00068	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—IL3—Crohn's disease	0.000114	0.000679	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000114	0.000678	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—SEL1L—Crohn's disease	0.000113	0.000677	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000113	0.000673	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—FADS1—Crohn's disease	0.000111	0.000662	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00011	0.000656	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—MTMR3—Crohn's disease	0.00011	0.000655	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.00011	0.000654	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000107	0.000637	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—GPX4—Crohn's disease	0.000104	0.00062	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CCR9—Crohn's disease	0.000104	0.000619	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—IL3—Crohn's disease	0.000103	0.000616	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—PTGER4—Crohn's disease	0.000102	0.000612	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PLA2G4F—Crohn's disease	0.000102	0.000608	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—GCKR—Crohn's disease	0.0001	0.000599	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	9.99e-05	0.000597	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—RASGRP1—Crohn's disease	9.98e-05	0.000596	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—CXCL8—Crohn's disease	9.86e-05	0.000589	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	9.82e-05	0.000587	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—GPR65—Crohn's disease	9.65e-05	0.000576	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—IL3—Crohn's disease	9.61e-05	0.000574	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	9.59e-05	0.000573	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—TNF—Crohn's disease	9.43e-05	0.000563	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—FADS1—Crohn's disease	9.41e-05	0.000562	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—FADS1—Crohn's disease	9.33e-05	0.000557	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—RASGRP1—Crohn's disease	9.29e-05	0.000555	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CCR6—Crohn's disease	9.27e-05	0.000554	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	9.12e-05	0.000545	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—IL2RA—Crohn's disease	9.08e-05	0.000542	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PLA2G4F—Crohn's disease	8.82e-05	0.000526	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—GPX4—Crohn's disease	8.81e-05	0.000526	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—GPX4—Crohn's disease	8.73e-05	0.000521	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL3—Crohn's disease	8.72e-05	0.000521	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	8.68e-05	0.000518	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—MTMR3—Crohn's disease	8.66e-05	0.000517	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—CXCL8—Crohn's disease	8.64e-05	0.000516	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—FADS1—Crohn's disease	8.55e-05	0.00051	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	8.54e-05	0.00051	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—GCKR—Crohn's disease	8.51e-05	0.000508	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—RASGRP1—Crohn's disease	8.44e-05	0.000504	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—GCKR—Crohn's disease	8.44e-05	0.000504	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—RBX1—Crohn's disease	8.39e-05	0.000501	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—IL2RA—Crohn's disease	8.25e-05	0.000492	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—PTGER4—Crohn's disease	8.17e-05	0.000487	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CCR6—Crohn's disease	8.13e-05	0.000486	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—TYK2—Crohn's disease	8.04e-05	0.00048	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—GPX4—Crohn's disease	8.01e-05	0.000478	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—IL2RA—Crohn's disease	7.96e-05	0.000475	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PLA2G4F—Crohn's disease	7.87e-05	0.00047	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—GCKR—Crohn's disease	7.73e-05	0.000462	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PLA2G4F—Crohn's disease	7.68e-05	0.000459	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—JAK2—Crohn's disease	7.67e-05	0.000458	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—MTMR3—Crohn's disease	7.5e-05	0.000448	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—UBE2D1—Crohn's disease	7.35e-05	0.000439	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—RBX1—Crohn's disease	7.35e-05	0.000439	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—CXCL8—Crohn's disease	7.31e-05	0.000436	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	7.24e-05	0.000432	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—IL2RA—Crohn's disease	7.23e-05	0.000432	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	7.18e-05	0.000428	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	7.17e-05	0.000428	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—PTGER4—Crohn's disease	7.16e-05	0.000427	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—RIPK2—Crohn's disease	7.13e-05	0.000426	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—CXCL8—Crohn's disease	7e-05	0.000418	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL3—Crohn's disease	6.95e-05	0.000415	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	6.89e-05	0.000411	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CCR6—Crohn's disease	6.87e-05	0.00041	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—FADS1—Crohn's disease	6.74e-05	0.000403	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—IL2RA—Crohn's disease	6.73e-05	0.000402	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—RASGRP1—Crohn's disease	6.73e-05	0.000402	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—MTMR3—Crohn's disease	6.69e-05	0.000399	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—IL6—Crohn's disease	6.66e-05	0.000397	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—MTMR3—Crohn's disease	6.53e-05	0.00039	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—UBE2D1—Crohn's disease	6.45e-05	0.000385	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—GPX4—Crohn's disease	6.31e-05	0.000377	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	6.27e-05	0.000374	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—RIPK2—Crohn's disease	6.25e-05	0.000373	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—RBX1—Crohn's disease	6.22e-05	0.000371	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—MTMR3—Crohn's disease	6.15e-05	0.000367	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	6.13e-05	0.000366	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL2RA—Crohn's disease	6.11e-05	0.000365	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—JAK2—Crohn's disease	6.1e-05	0.000364	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—MTMR3—Crohn's disease	6.1e-05	0.000364	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL3—Crohn's disease	6.1e-05	0.000364	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—GCKR—Crohn's disease	6.1e-05	0.000364	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—SOCS1—Crohn's disease	6.09e-05	0.000364	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—PTGER4—Crohn's disease	6.05e-05	0.000361	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—RASGRP1—Crohn's disease	5.9e-05	0.000352	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—FADS1—Crohn's disease	5.84e-05	0.000349	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—TYK2—Crohn's disease	5.81e-05	0.000347	CbGpPWpGaD
Buprenorphine—ABCG2—Transmembrane transport of small molecules—ALB—Crohn's disease	5.78e-05	0.000345	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—STAT3—Crohn's disease	5.63e-05	0.000336	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—CXCL8—Crohn's disease	5.57e-05	0.000333	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—JAK2—Crohn's disease	5.54e-05	0.000331	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GPX4—Crohn's disease	5.47e-05	0.000326	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—UBE2D1—Crohn's disease	5.45e-05	0.000325	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—JAK2—Crohn's disease	5.35e-05	0.00032	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—SOCS1—Crohn's disease	5.34e-05	0.000319	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—RIPK2—Crohn's disease	5.29e-05	0.000316	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GCKR—Crohn's disease	5.28e-05	0.000315	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—SMAD3—Crohn's disease	5.26e-05	0.000314	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—MTMR3—Crohn's disease	5.21e-05	0.000311	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—FADS1—Crohn's disease	5.21e-05	0.000311	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL3—Crohn's disease	5.15e-05	0.000308	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—TYK2—Crohn's disease	5.1e-05	0.000304	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—FADS1—Crohn's disease	5.09e-05	0.000304	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—CXCL8—Crohn's disease	5.06e-05	0.000302	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—RASGRP1—Crohn's disease	4.99e-05	0.000298	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—CXCL8—Crohn's disease	4.89e-05	0.000292	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GPX4—Crohn's disease	4.88e-05	0.000291	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL2RA—Crohn's disease	4.87e-05	0.000291	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—JAK2—Crohn's disease	4.86e-05	0.00029	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—FADS1—Crohn's disease	4.79e-05	0.000286	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GPX4—Crohn's disease	4.76e-05	0.000284	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—FADS1—Crohn's disease	4.75e-05	0.000284	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	4.73e-05	0.000283	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GCKR—Crohn's disease	4.71e-05	0.000281	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	4.65e-05	0.000278	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—SMAD3—Crohn's disease	4.61e-05	0.000275	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GCKR—Crohn's disease	4.6e-05	0.000275	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—JAK2—Crohn's disease	4.52e-05	0.00027	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—SOCS1—Crohn's disease	4.52e-05	0.00027	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GPX4—Crohn's disease	4.49e-05	0.000268	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GPX4—Crohn's disease	4.45e-05	0.000266	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—CXCL8—Crohn's disease	4.44e-05	0.000265	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GCKR—Crohn's disease	4.34e-05	0.000259	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—TYK2—Crohn's disease	4.31e-05	0.000257	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GCKR—Crohn's disease	4.3e-05	0.000257	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL2RA—Crohn's disease	4.27e-05	0.000255	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—CXCL8—Crohn's disease	4.13e-05	0.000246	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—JAK2—Crohn's disease	4.11e-05	0.000245	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—FADS1—Crohn's disease	4.06e-05	0.000242	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—ALB—Crohn's disease	4.04e-05	0.000241	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—MTMR3—Crohn's disease	4.02e-05	0.00024	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—IL6—Crohn's disease	3.93e-05	0.000235	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—SMAD3—Crohn's disease	3.9e-05	0.000233	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GPX4—Crohn's disease	3.8e-05	0.000227	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.77e-05	0.000225	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CXCL8—Crohn's disease	3.75e-05	0.000224	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GCKR—Crohn's disease	3.67e-05	0.000219	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL2RA—Crohn's disease	3.61e-05	0.000216	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—PTGS2—Crohn's disease	3.53e-05	0.000211	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TYK2—Crohn's disease	3.43e-05	0.000205	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.37e-05	0.000201	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.3e-05	0.000197	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—JAK2—Crohn's disease	3.27e-05	0.000195	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—ALB—Crohn's disease	3.19e-05	0.000191	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—FADS1—Crohn's disease	3.13e-05	0.000187	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	3.13e-05	0.000187	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.07e-05	0.000183	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TYK2—Crohn's disease	3.01e-05	0.00018	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CXCL8—Crohn's disease	2.99e-05	0.000178	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.95e-05	0.000176	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GPX4—Crohn's disease	2.94e-05	0.000175	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—JAK2—Crohn's disease	2.87e-05	0.000171	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—IL6—Crohn's disease	2.84e-05	0.00017	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GCKR—Crohn's disease	2.84e-05	0.000169	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PTGS2—Crohn's disease	2.79e-05	0.000167	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—ALB—Crohn's disease	2.71e-05	0.000162	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.69e-05	0.00016	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—ALB—Crohn's disease	2.68e-05	0.00016	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.63e-05	0.000157	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CXCL8—Crohn's disease	2.62e-05	0.000156	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TYK2—Crohn's disease	2.54e-05	0.000152	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—IL6—Crohn's disease	2.49e-05	0.000149	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—ALB—Crohn's disease	2.46e-05	0.000147	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—JAK2—Crohn's disease	2.43e-05	0.000145	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—STAT3—Crohn's disease	2.4e-05	0.000143	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PTGS2—Crohn's disease	2.37e-05	0.000141	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PTGS2—Crohn's disease	2.35e-05	0.00014	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.3e-05	0.000137	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CXCL8—Crohn's disease	2.21e-05	0.000132	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PTGS2—Crohn's disease	2.15e-05	0.000129	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—STAT3—Crohn's disease	2.11e-05	0.000126	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL6—Crohn's disease	2.11e-05	0.000126	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ALB—Crohn's disease	1.94e-05	0.000116	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—STAT3—Crohn's disease	1.78e-05	0.000106	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PTGS2—Crohn's disease	1.7e-05	0.000101	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ALB—Crohn's disease	1.68e-05	0.0001	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL6—Crohn's disease	1.68e-05	0.0001	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ALB—Crohn's disease	1.5e-05	8.96e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL6—Crohn's disease	1.47e-05	8.79e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PTGS2—Crohn's disease	1.47e-05	8.78e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ALB—Crohn's disease	1.46e-05	8.74e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ALB—Crohn's disease	1.38e-05	8.24e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ALB—Crohn's disease	1.37e-05	8.17e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PTGS2—Crohn's disease	1.31e-05	7.84e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PTGS2—Crohn's disease	1.28e-05	7.65e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL6—Crohn's disease	1.24e-05	7.43e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PTGS2—Crohn's disease	1.21e-05	7.21e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PTGS2—Crohn's disease	1.2e-05	7.15e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ALB—Crohn's disease	1.17e-05	6.98e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PTGS2—Crohn's disease	1.02e-05	6.11e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ALB—Crohn's disease	9.02e-06	5.39e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PTGS2—Crohn's disease	7.89e-06	4.71e-05	CbGpPWpGaD
